1.8 million euros for an innovative project at the Rudolf Virchow Center

About 4.3 million euros for two innovative projects of the University of Würzburg

"The Translation Network for the Research and Diagnosis of Thrombo-Inflammatory Diseases" at the Rudolf Virchow Center for Experimental Biomedicine at the University of Würzburg addresses heart attack and stroke research (Nieswandt Group). In close cooperation with regional companies, it elaborates methods for diagnosis as well as early identification markers, in order to be able to identify the risk of hemorrhage in patients. Medicines which are suitable for the treatment of patients are also to be developed. The project is funded with around 1.8 million euros.

"Universities are central research facilities. They are, for example, decisively involved in the development of new forms of therapy in medicine. Based on their findings, companies are able to produce appropriate medical drugs and devices that enable state-of-the-art treatments. The Bavarian Ministry of Science and Research supports two innovative projects, which the University of Würzburg is implementing together with regional companies, with a total of over 4.3 million euros from the European Regional Development Fund," the Minister of Science Dr. Ludwig Spaenle announced today in Munich. "The university cooperates closely with local companies on the application-oriented research projects focusing on cancer therapy as well as on heart attack and stroke diagnosis and treatment. Thus science and economy are working together on a medical progress and the best possible treatment methods for the patients."

The Chair of Biotechnology and Biophysics of the University of Würzburg is setting up a "Center for Personalized Molecular Immunotherapy" together with the University Clinic of Würzburg (UKW). In the context of application-oriented research, new methods of immunotherapy for cancer patients are being explored and appropriate methods are developed by regional biomedical and technical companies. The treatment can, for example, be used instead of chemotherapy. The project is supported by over 2.5 million euros.

48 million euros for technology transfer between universities and medium-sized companies

The European Regional Development Fund (EFRE) will provide the Ministry of Science funding of 48 million euro over the period 2014 to 2020. It promotes projects that universities can implement together with small and medium-sized enterprises in the region. The goal is to improve the transfer of technology between science and industry and to strengthen the innovative capacity of regional companies.

Press release of the Bavarian Ministry of Education and Culture, Science and Art

In the press: Bayerischer Rundfunk - BR.de "Finanzspritze für Uni Würzburg - 4,3 Millionen Euro zur Krebs- und Schlaganfallforschung"

Contact:

Prof. Dr. Bernhard Nieswandt, Tel.:+49 931 31-80406
bernhard.nieswandt@virchow.uni-wuerzburg.de

Created by Dr. Daniela Diefenbacher (Pressestelle, Rudolf-Virchow-Zentrum)
Tel. 0931 3188631, daniela.diefenbacher@uni-wuerzburg.de